Public reporting burden for this collection of information is estimated to average 1 hour per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing this collection of information. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to Washington Headquarters Services, Directorate for Information Operations and Reports. 1215 Loss of tissue polarity and increased proliferation are the characteristic alterations of the breast tumor phenotype.
INTRODUCTION
Epithelial cancers are caused by multiple genetic lesions that eventually lead to both aberrant proliferation/apoptosis and loss of polarity. Although a variety of oncogenes, especially oncogenic kinases have been shown to transform normal cells in vitro and to result in tumor formation in vivo, the complexity of their signaling networks implicated that their downstream effectors could be subgrouped into functionally distinct branches at certain level, which might controls various activities, such as proliferation and polarity respectively. By using a 3 dimensional rBM culture system and human mammary epithelial cell progression series, we previously showed that polarity could be restored and proliferation reduced in human mammary epithelial cancer cells when P13 kinase (P13K) overactivation was diminished. In order to further dissect the molecular mechanisms of the reversion and to distinguish if proliferation and polarity are two separable events downstream of P13K signaling pathways that eventually integrate and synergistically contribute to tumor development, the activities of effectors, such as Akt and Racl that regulate proliferation
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and polarity, were genetically manipulated of P13K and its phospholipid product PIP3
Cell lysates from S-1, T4-2, and was re-established in the reverted spheres. grown in 3D IrBM or on 2D plastic substrata
The evidence that inhibition of P13K can for 10 days were analyzed for expression of effect crossmodulation of a number of (A) EGFR, 131 integrin, total/phosphorylated distinct signaling pathways is a demonstration Akt (serine 473), total/phosphorylated GSK-313 (serine 9), and (B) PTEN; E-cadherin was that pathways downstream of PI3K are used as the loading control. integrated into transduction networks when usedastheloadingcontrol. cells are grown in the physiological 3D rBM; consistent with this model, we found that reversion of the tumor cells to a normal phenotype was associated with down-modulation of EGFR and P I integrin and increased expression of PTEN, the P13K antagonist ( Figure  1A , B).These observations suggest that dysregulated P13K activity has profound effects on both proliferation and polarity. We tried to determine if tumorigenic T4-2 cells could be also reverted if the expression of PTEN, a phospholipids phosphatase and antagonist of P13K signaling (Vazquez and Sellers, 2000) , was up-regulated. However, we could not obtain stable population because cells died once they overexpressed PTEN-GFP construct.
The primary consequence of P13K activation is the generation of PIP3 in the membrane, which functions as a second messenger to activate downstream pathways that involve Akt and other proteins such as SGK, RSK, atypical PKC, and Racl (Vivanco and LY294002 + Sawyers, 2002) . Akt has been shown to be one of the most important effector that mediates PI3K's effects on cellular proliferation and apoptosis . P13K can also affect Racl activity by regulating the activity of its GTP/GDP exchange factors (GEF) such as Tiaml and Vavl . Racl is one of major components of an evolutionarily conservative protein My-u complex (PAR3/PAR3/aPKC) that plays an important role in tight junction formation and regulation of polarity development (Kim, 2000) . Dysregulated Racl activity leads to a loss of polarity owing to the failure Raci L61
to deposit the ECM component laminin asymmetrically ). In addition, an alternative splice variant of Racl (Raclb) with increased GTP/GDT exchange rate is highly expressed in breast -and colon carcinoma (Schnelzer et al., 2000) .
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As the effectors downstream of PI3K could regulate both proliferation and probably cell polarity, we hypothesized that the signaling pathways of P13K might bifurcate into function-specific signaling groups. In order constructs (active Akt+Racl L61 or active Akt+Racl N17) and determined their effects on the reversion phenotypes mediated by P13K-specific inhibitors, such as LY294002 or' wortmannin, in 3D rBM culture system. We also tried to knock down endogenous Akli by RNAi or use adenoviral constructs of 5 Racl V12 and N17. However, the cells could not survive or die as the result of cytotoxic effects of adenovirus.
We observed that active Akt endowed tumorigenic T4-2 cells with greater resistance to proliferation reduction induced by P13K down-modulation in 3D rBM assay. Intriguingly, active Akt did not prevent the re-establishment of basal tissue polarity (Figure 2 ) although it drastically augmented cell's ability to grow in anchorageindependent assays (Figure 3) . Our results are consistent with another recent study in that active Akt, when overexpressed, increased Vectors Myr-Akt Racl L61 the size and cell number of the cysts VMa formed by MCF-I OA cells, a transformed, nonmalignant mammary epithelial cell line, but their basal polarity was maintained in 3D rBM assay (Debnath et Now came the question as to which effector downstream PI3K controlled polarity. We found that GTP-loaded Racl level was substantially higher in malignant T4-2 cells than their nonmalignant counterpart Si cells and did decrease when P13K activity was down-modulated ( Figure 4 ) and that in contrast to the cells expressing active Akt mutant, normalization of P13K activity could substantially reduce cell proliferation to the level as treated vector control or parental cells, however, basali51 1, T4-2 cells treated with vehicle or mr P13K inhibitor LY 294002. signaling to mediate the loss of tissue polarity without significant effect on cell proliferation and this pathway of polarity regulation is separated from the pathway that controls cell proliferation; second, aberrant proliferation (through increased Akt activity) and loss of polarity (via up-regulated Racl activity) constitute the minimal signaling inputs required from P13K to cause tumor phenotypes; third, disruption of polarity is one of the major requirements or enhancers for epithelial tumorigenesis once cell proliferation becomes uncontrollable. To further test this model, we injected those transfectants (vector control, active Akt, Racl L61, Racl N17, active Akt+Racl L61, and active Akt+Racl N17) into nude mice (n=6 for each group) and observed the tumor growth in vivo. We found that active Akt but not Racl L61 greatly increased tumor size and that double transfectants of active Akt and Racl L61 synergistically led to much larger tumor than active Akt alone ( Figure 5 3. Determine the role of acive Racl signaling in the prevention of polarity restoration in P13K attenuation-mediated phenotypical reversion in 3D rBM assay without effect on cell proliferation.
4. Determine the role of active Akt in the partial prevention of the reduction of cell proliferation in P13K attenuation-mediated reversion in 3D rBM assay without effect on polarity restoration.
5. Determine that loss of the control of both polarity (by overactive Racl) and proliferation (by overactive Akt) is sufficient to totally prevent the phenotypical reversion by P13K down-modulation in 3D rBM.
6. Determine that active Akt signaling endows the cells with much greater ability to grow in anchorage-independent assay and that double transfectants of active Akt and active Racl but not inactive mutant synergistically promotes the growth in the same assay. 
CONCLUSIONS
In conclusion, we have used the 3D rBM assay and genetic manipulation of Akt and Racl activity to determine the role of P13K signaling in the tumorigenic phenotype, signaling reorganization, and tissue polarity of mammary epithelial cells. Our elucidation that the polarity and proliferation are controlled independently by separable events downstream of P13K sheds light on the molecular mechanisms by which increased proliferation and loss of tissue polarity act as function-specific pathways to affect various cell phenotypes even under one overactive kinase signaling pathway and the aberration of both phenotypes are required to produce the malignant phenotype, which might be generalized to other signaling pathways or models to dissect the process of tumor development. To investigate these processes, we used a by inhibition of P13K signaling also down-modulates the three-dimensional (3D) culture system in which malignant endogenous levels of 031 integrin and epidermal growth human breast cells can be reverted to a normal phenotype factor receptor, the upstream modulators of P13K, and by exposure to inhibitors of phosphatidylinositol 3-kinase up-regulates PTEN, the antagonist of P13K. These findings (P13K). Using this assay, we find that Akt and Racl act as reveal key events of the P13K pathway that play distinct downstream effectors of P13K and function as control points roles to maintain tissue polarity and that when disrupted of cellular proliferation and tissue polarity, respectively, are instrumental in the malignant phenotype. Our results also demonstrate that the P13K signaling Introduction Class I phosphatidylinositol 3-kinase (P13K) is activated human mammary epithelial cells is sufficient to confer a by growth factor-responsive tyrosine kinases such as epidermalignant phenotype (Zhao et al., 2003) . mal growth factor receptor (EGFR; Grant et al., 2002) and During tumor progression, tissue polarity is lost and integrin-responsive kinases such as focal adhesion kinase control of proliferation is compromised (Fish and Molitoris, (FAK; Chen and Guan, 1994) . Activated P13K leads to the 1994; Reichmann, 1994; Bissell and Radisky, 2001) , and production of membrane-associated phosphatidylinositol although these two phenomena have been suggested to be 3,4,5-trisphosphate (PIP3), which in turn causes the recruitlinked, previous investigations have not revealed the extent ment to the cell membrane and subsequent activation of a to which the increased cellular proliferation in tumors can number of signaling molecules (Vivanco and Sawyers, 2002) . directly produce tissue disorganization, and to what extent P13K is a key mediator in processes that regulate cell orientaloss of polarity is an independent function of deregulated tion; for both Dictyostelium and cultured human leukocytes, signaling pathways downstream of the oncogenic signal(s). directionality of chemotaxis is controlled by polarization of To dissect the molecular mediators of these processes we PIP3 to the leading edge of the cell (Servant et al., 2000;  have used an assay (Petersen et al., 1992) in which human Funamoto et al., 2002; Wang et al., 2002b) . P13K has been mammary epithelial cells from the HMT-3522 tumor found to be constitutively up-regulated in a substantial progression series are cultured in a physiologically relevant, fraction of human breast cancers (Vivanco and Sawyers, three-dimensional (3D) laminin-rich basement membrane 2002), and overexpression of P13K in cultured nonmalignant (lrBM). When cultured in 3D IrBM, the phenotypically normal, nonmalignant HMT-3522 S-1 (S-1) cells undergo growth arrest, produce an endogenous basement membrane, (Chen and Guan, 1994; Lee and Juliano, 2000; Grant et al., 2002) , we hypothesized that the phenotypic reversion affected by down-modulation of EGFR/[31 integrin C signaling in T4-2 cells was due to attenuation of P13K activity. We showed previously that even highly malignant metastatic cancer cells, cultured in 3D IrBM, could be reverted to Results assessed for each experiment, n = 3), and anchorage-independent Down-modulation of P13K activity results in phenotypic growth (right, soft agar assay, colonies scored positive when >50 fim, n = 3). reversion of human mammary tumor cells We found previously that malignant T4-2 cells showed increased signaling from EGFR and 131 integrin, relative to property of forming polarized, growth-arrested structures in their nonmalignant predecessors, and that down-modularesponse to a physiologically relevant microenvironment. tion of either EGFR or 131 integrin activity in cells grown in 3D IrBM caused the cells to form growth-arrested, polarized Phenotypic reversion is accompanied by repolarization acinus-like structures (Weaver et al., 1997; of P13K and its phospholipid product 1998). As P13K is an effector of both of these signaling pathProper interpretation of extracellular signaling cues requires ways (Chen and Guan, 1994; Lee and Juliano, 2000 ; Grant asymmetric distribution of intracellular signaling molecules et al., 2002), we hypothesized that inhibition of P13K sig- (Comer and Parent, 2002; Wedlich-Soldner and Li, 2003) . naling would also revert these cells. We found that treatment Recently, signaling asymmetry of P13K and its lipid prodof T4-2 cells with 8 p.M of the P13K inhibitor LY294002 uct, PIP3 has been shown to control the directionality of (which prevented phosphorylation of downstream Akt at chemotactic migration in human neutrophils and in single serine 473, as well as other downstream signaling mediators Dictyostelium cells (Servant et al., 2000; Funamoto et al., glycogen synthase kinase-3p3 [GSK-3P3] and p70S6K; Fig. 1 2002; Wang et al., 2002b) , and PIP3 has been found to be-B) did cause phenotypic reversion, as characterized by inhicome polarized to the basal surface of MDCK cells grown as bition of proliferation, decreased colony size, and reduced monolayers on filters or in 3D collagen gels (Watton and growth in soft agar cultures (Fig. 1, A and C) . Using indirect Downward, 1999; Yu et al., 2003) . We found that both immunofluorescence, we found that the LY294002-reverted P13K (p 8 5 subunit) and PIP3 are polarized to the basal sur-'[4-2 cells regained the polarization of the apicolateral tight face of phenotypically normal S-1 cells grown in 3D IrBM, junction marker ZO-I, the basal marker a6 integrin, and and that this asymmetric distribution is lost in T4-2 cells the reorganization of the actin cytoskeleton (Fig. 2 A) . Simi- (Fig. 2 B) . However, phenotypic reversion of the T4-2 cells lar data were obtained in cells treated with the alternative through attenuation of P13K signaling led to repolarization P13K inhibitor, wortmannin (unpublished data). These reof these signaling components (Fig. 2 B) . Given that the S-I stilts demonstrate that down-regulation of the P13K pathand reverted T4-2 cells show correct tissue polarity, whereas way in T4-2 mammary tumor cells restores an intrinsic the untreated T4-2 cells are apolar, these results provide the A S1 T4-2 T4-2+ LY Nuclei PIP3 Nuclei first evidence that polarized distribution of P13K and PIP3 is vealed that PTEN, the antagonist of P13K that acts to dean intrinsic property of phenotypically normal acini that is phosphorylate PIP3 and which becomes down-regulated in lost during tumor progression. many carcinomas (Simpson and Parsons, 2001; Yamada and Araki, 2001) , is also a component of the cross-moduPhenotypic reversion of T4-2 cells by treatment lated signaling network, as treatment of T4-2 cells with with LY294002 results in cross-modulation of LY294002 resulted in an increase of PTEN to the level of multiple signaling pathways the nonmalignant cells; this modulation, too, was seen only
APPENDICES
We had shown previously that inhibition of either EGFR or in cells cultured on 3D IrBM (Fig. 3 B) . Taken together, p31 -integrin results in phenotypic reversion of T4-2 cells asthese results demonstrate the existence of a retrodirectional sociated with down-modulation of the total levels of both control network that exists only when cells are cultured in a signaling molecules, and that this activity influences and is proper tissue context. influenced by the MAPK signaling pathway (Wang et al., 1998). We now show that P13K signaling is also an integral Increased proliferation and loss of tissue polarity component of this cross-modulated signaling network. T4-2 are functionally separable consequences of increased cells treated with LY294002 show reduced levels of EGFR P13K signaling and [31 integrin (Fig. 3 A) . This effect depended upon 3D P13K has been found to control a wide variety of downstream IrBM as it is not observed in cells cultured on two-dimensignal transduction pathways, the number and composition sional (2D) plastic substrata (it should be noted that inhibiof which vary according to cell and tissue type (Chan et al., tion of P13K activity, as measured by activation of down-1999; Vanhaesebroeck et al., 2001 ). The best-studied effecstream mediators Akt and GSK-3p3, was equally effective in tor of P13K is Akt, a regulator of cellular proliferation and cells on 2D or in 3D; Fig. 3 A) . In addition, our results reapoptosis These results demonstrated that the increased P13K sig-P-GSK-3f1
4
A naling in T4-2 cells, relative to the same cells treated with
GSK-3P3
LY294002 or to the nonmalignant S-1 cells, leads to activation of both Racl and Akt, and that these effectors signal to E-Cadherin two functionally distinct phenotypes: activation of Racl causes the loss of cellular polarity, and activation of Akt B X\ causes increased proliferation. To determine whether to-__V gether these two effectors were sufficient to recapitulate the PTEN __________ MOP_ effects of P13K, T4-2 cells were infected with both constructs (Fig. 6 A) . Colonies derived from cells transfected E-Cadherin _____ _ _
•• with these constructs were considerably larger than from -......
control vector-infected cells. Treatment with P13K inhibitor
3D BM 2D plastic substrata reduced the increased proliferation only to the level of the malignant vector-transfected cells (Fig. 6 , B and C), but it Figure 3 . Attenuation of P13K activity results in cross-modulation had no repolarizing effect (Fig. 6 D) . To determine whether of other signaling pathways and intermediates. Cell lysates from S-1, these effects were also manifested in a different surrogate tu-T4-2, and T4-2+LY grown in 3D lrBM or on 2D plastic substrata for 10 d were analyzed for expression of (A) EGFR, 131 integrin, phosmor malignancy assay, the four cell types (T4-2, T4 -Myrphorylated Akt (serine 473)/total, phosphorylated GSK-313 (serine 9)/ Akt, T4+RaclL61, and T4+MyrAkt+Raci L61) were cultotal, and (B) PTEN (n = 3); E-cadherin was used as the loading contured in 3D methylcellulose in the absence or presence of trol. It was shown previously that the total level of E-cadherin LY294002 (Fig. 6 E possibility that the P13K inhibitor-mediated reversion was due to reduction of Akt activity by expressing a dominant ac-
Discussion
tive Akt construct (Myr-Akt) in the T4-2 cells (Fig. 4 A) . Ex-A number of studies have shown that the P13K signaling pression of this construct blocked the effect of P13K inhibitor pathway becomes dysregulated in many types of carcinoma on phosphorylation of Akt and downstream mediators of Akt (Vivanco and Sawyers, 2002) . The results presented here deactivity (Fig. 4 B) , and substantially increased the proliferafine mechanisms by which the high activity of P13K in mation of ''4-2 cells (Fig. 4, C and D) . However, examination lignant T4-2 human breast cells contributes to their maligof colony polarity revealed that the LY294002-treated T4-nant phenotype. We find that down-modulation of P13K Myr-Akt cell spheroids largely retained basal tissue polarity activity in the T4-2 cells grown in 3D IrBM causes strucdespite their considerably larger size (Fig. 4, E and F) . This tural repolarization and reversion to a nonmalignant phenoresult revealed that increased proliferation alone was not suftype (Fig. 1 ) similar to the effects observed previously from ficient to disrupt tissue polarity in the reverted T4-2 cells inhibition of EGFR and P31 integrin (Weaver et al., 1997;  (which retain all of their phenotype-altering genetic muta- , and we additionally show that both the tions), and suggested that other effectors of P13K might be normal and the normalized reverted acinus-like structures responsible for disruption of tissue polarity, had basal polarization of P13K and its lipid signaling prodRecent investigations of acinus-like cysts of MDCK cells uct, PIP3 (Fig. 2 B) . The evidence that inhibition of P13K grown in 3D collagen gels have demonstrated a role for Racl can affect crossmodulation of a number of distinct signaling in control of cellular polarity . When pathways is a demonstration that pathways downstream of we examined the activity of Racl in S1, T4-2, and P13K are integrated into transduction networks when cells LY294002-reverted T4-2 cells using pull-down assays, we are grown in the physiological 3D IrBM; consistent with this found a high correlation of active RacI levels with loss of tismodel, we found that reversion of the tumor cells to a norsue polarity (Fig. 5 A) . To test the role of Racl in the revermal phenotype was associated with increased expression of sion phenotype, we expressed a dominant active Racl con-PTEN, the P13K antagonist (Fig. 3 B) . Looking for the sigstruct in T4-2 cells (RaclL61; Fig. 5 B) . We found that this naling effectors that controlled the increased proliferation construct did not greatly affect the rate of cellular proliferaand decreased polarity downstream of P13K in the T14-2 cells tion (Fig. 5, C and D) , but did inhibit the restoration of poled to identification of Akt as a mediator of increased proliflarity in response to LY294002 (Fig. 5, E and F) . Although eration (Fig. 4) and RacI as an inhibitor of polarization (Fig. the inhibition of reversion by the RacI L61 was incomplete, 5), and we found that these two genes, when expressed in this was most likely due to the heterogenous expression of combination, were sufficient to overcome the inhibition of 
U) 10
test; more than 500 colonies from 5 independent + LY 0 experiments were analyzed for each condition). (Fig. 6) . These results suggest a model in which the any other T4-2 reversion reagent) results in a cell system that key aspects of the early malignant phenotype, growth and is genetically malignant but biochemically normal, and the disorganization, can be controlled through disruption of sigconsequences of manipulating a single signaling pathway in naling pathways that become interconnected and integrated reverted cells provides information directly relevant to basic in 3D IrBM (Fig. 7) .
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characteristics of malignant cell behavior. Using this model, It is an important consideration, however, that the progreswe now show how the altered signaling pathways in T4-2 tosively increased proliferation and disorganization that typify mor cells may contribute to the tumor phenotype, how the acquisition of malignancy in mammary epithelial cells is due functions of master regulators (such as P13K) may be disto more than just P13K-dependent activation of Racl and sected in terms of downstream signaling pathways (in this Akt (although combined activation of these two pathways case, Racl and Akt), and how manipulation of these pathhas been shown to be sufficient to confer malignancy in an ways can cause the tumor cells to adopt a normal phenotype. experimental model of premalignant human mammary epiNormalization of signaling pathways in T4-2 cells in rethelial cells; Zhao et al., 2003) . During tumor progression sponse to inhibition of P13K is dependent upon culture in there are many genetic and epigenetic alterations that to-3D IrBM, as T4-2 cells grown on 2D tissue culture plastic do gether contribute to produce malignancy; for the progression not show the dramatic downmodulation of PI integrin and of S-1 to T4-2 cells, these include induction of many path-EGFR (Fig. 3 A) , up-regulation of PTEN (Fig. 3 B) , or the ways likely not directly related to P13K signaling. Reversion alterations in cellular morphology in response to treatment of the T4-2 tumor cells grown in 3D suppresses most (if not with inhibitors of P13K (Figs. 2 and 3) . Also, for T4-2 cells all) of these other pathways, reducing the proliferation and grown in 3D IrBM, the reduction in P13K signaling is paralrestoring polarity, but does not change the fact that the releled by a reorganization of signaling orientation, as both verted cells still retain all of the same genetic alterations and P13K and its phospholipid product, PIP3, became repolarabnormalities. Thus, reversion (whether by LY294002 or by ized to the basolateral surface of the reorganized T4-2 cell 
+ LY< 0
Racl L61 -+ + (f6 integqin / Nuclei LY -+ + structures (Fig. 2) . This basolateral distribution of P13K and tacts is an essential component of ECM-induced cell polarity P1iP3 might indeed reflect the localization of active cell sur- (Weaver et al., 1997 (Weaver et al., , 2002 Yeaman et al., 1999) . If so, then face receptors, e.g., integrins and receptor tyrosine kinases, formation of tight junctions at points of cell-cell contact may many of which have particular functions when localized to provide boundaries for localization of P13K and other signalthe basal or basolateral surfaces (Playford et al., 1996;  Weaver ing effectors such as integrins and growth factors that then et al. , 1997; Vermeer et al., 2003) . Basolateral polarization of provide the polarizing principle. These possibilities are under PIP3 has been suggested to be a critical determinant of differinvestigation. entiated tissue behavior in polarized MDCK cells grown as
We have found that the 3D presentation of IrBM is essenmonolayers on filters (Watton and Downward, 1999) or as tial for coupling the expression levels and activity of EGFR cysts in 3D collagen gels (Yu et al., 2003) , and PIP3 becomes and 131 integrin in cultured mammary epithelial cells (Wang apolarly distributed in the plasma membrane during branchet al., 1998) , and evidence in other systems also implicates ing morphogenesis (Yu et al., 2003) , a process believed to inreorganization of signaling pathways in cells cultured in 3D
volve the transitory dedifferentiation to a migratory and inIrBM (Cukierman et al., 2001 (Cukierman et al., , 2002 Muthuswamy et al., vasive state that is highly reminiscent of the malignant 2001). We now show that components of the P13K signalphenotype. P13K signaling polarization is also an essential ing pathway are involved in this cross-modulation process, component of chemotactic migration in neutrophils and Dicas phenotypic reversion by inhibition of P13K is associated tyostelium (Servant et al., 2000; Funamoto et al., 2002; Wang with, and presumably, supported by, up-regulation of the et al., 2002b) , and the directionality of neuronal axon growth P13K antagonist, PTEN (Fig. 3) . This also requires the esis controlled by spatially localized P13K activity (Shi et al., tablishment of organized structures in 3D IrBM, as treat-2003). Our observations in mammary epithelial cells do not ment of T4-2 cells with P13K inhibitors does not result in reveal the extent to which the polarized distribution of P13K up-regulation of PTEN when cells are grown on 2D plastic and PIP3 causes, or is the consequence of, tissue polarity, but substrata (Fig. 3 B) . Given that the signaling reorganization previous observations with these cells in 3D ArBM and with associated with reversion of T4-2 cells is associated with glo-MDCK cysts have suggested that formation of cell-cell conbal repolarization of signaling molecules, we suggest that di- Myr-Akt
-LY rectional orientation of signaling is an essential component tent with our model in which additional abnormalities must of the cross-modulation process. In this regard, it is temptexist in addition to P13K activation in order for HMT3522 ing to speculate that the 3D IrBM-directed basal localizamammary epithelial cells to become tumorigenic. Overextion of P13K and PIP3 may explain why the cells in the pression of constitutively active Akt in T lymphocytes, panouter layer ofacini are more resistant to apoptosis than those creatic cells, and the mammary gland increases cellular pronot in contact with 3D IrBM (Debnath et al., 2002) . liferation and promotes survival but does not induce cellular High expression of P13K is commonly found in cancers transformation or increase tumor incidence (Vivanco and and cancer cell lines (Vivanco and Sawyers, 2002; Wang et Sawyers, 2002) , suggesting that additional factors must be al., 2002a), and there is considerable evidence that the activrequired. Racl isoforms are overexpressed in cancers of the ity of this enzyme is a key component of the tumorigenic breast and other organs, and increased activity of Racl or process. Cowden syndrome (an autosomal-dominant cancer Rac3 has been found in breast carcinoma cell lines and Raspredisposition syndrome caused by inherited mutations in transformed breast epithelial cells (Mira et al., 2000; Sahai PTEN) causes elevated risk of breast, thyroid, and skin tuand Marshall, 2002) . Here, we have unified the roles of elemors (Liaw et al., 1997) ; mice made heterozygous for exvated Racl and Akt activities in a simple mechanistic framepression of PTEN develop cancers at multiple sites (Di Criswork: we have found that the high levels of P13K in T4-2 tofano et al., 1998), and transgenic mice deficient for PTEN cells contribute to the loss of polarity and increased proliferexpression in the mammary gland developed tumors at early ation through Akt and Racl, and we find that these pathstage . Recent experiments using immortalways and phenomena are functionally separable. We find ized human mammary epithelial cells has shown that early that PI3K-Akt signaling is responsible for an appreciable inpassage cells require transfection of additional oncogenes crease in cell proliferation (Fig. 4) , whereas the P13K-Racl along with P13K (or Racl/Akt) to become malignant, signaling is responsible for the loss of basal tissue polarity whereas late passage cells (which presumably accumulate (Fig. 5) IrBM from Englebreth-Holm-Swarm tumors (matrigel), Vitrogen (rat tail collagen type I), and the antibodies for E-cadherin, 131 -integrin, EGFR, (16 integrin, and Ki-67 were described previously (Weaver et al., 1997; University) and production of retroviral stock were according to standard
+
Genetic mutants in this study protocols. The HMT-3522 mammary epithelial cells were infected at 40 50% confluence. Myr-Akt and Racl tL61-double transfectants were pro- Figure 7 . Scheme of proposed tumor cell signaling network to duced by sequentially infecting cells with each construct. The stably excontrol polarity, proliferation, and apoptosis. T4-2 signaling netpressing cells were selected in the presence of neomycin (500 itg/ml) or work. PI3K activity is increased in tumor cells as a result of aberrant hygromycin B (50 [tg/ml) and surviving clones were pooled. signaling from cell-ECM and cell-growth factor receptor interactions. The consequent activation of Akt contributes to the increased cellular immunoblotting, immunoprecipitation, and indirect proliferation through downstream pro-proliferation and anti-apoptotic immunoblooing and indirect immunofluorescence were performed as depathways. Increased PIP3 also leads to up-regulation of Racl through scribed previously (Weaver et al., 1997; Wang et ar., 1998p . For immunsactivation of Racl -specific GEE activity, resulting in altered organiprecipitation, cells were lysed in IP buffer () 'o Triton X-110, 150 mM Nat'l, zation of the actin cvtoskeleton, formation and maintenance of tight 1( mM TrisiHCl, pH 7.4, 1 mM EDTA, 1 mM EGTA, 2 mM NaF, 1 mM sojunctions, and directionality of vesicle trafficking, effects that combine dium orthovanadate, 10 ig/imI leupeptin, 10 p.g/ml pepstatin, 10 ig/mil to disorganize the tissue structure. Thus, each pathway independently aprotinin, 10 Rg/ml E 64, and 1 mM Pefabloc) and centrifuged at 10,00(1 g affects cellular behavior, but the synergistic effect leads to the tumor at 4'C. Equal amounts of protein lysates were precleared by 5(1 .I of protein phenotype. (*) Cross-modulation in 3D IrBM. Inhibition at any of G plus-conjugated agarise beads (Santa Cruz Biotechnology, Inc.) before these pressure points results in normalization of the expression and the addition of I [tg of primary antibody. Samples were incubated at 4'C activity at each of the other points, with concomitant normalization with gentle rotation for 1 h. Subsequently, samples were incubated with it0 of downstream signaling pathways.
p of protein G plus-conjugated beads for 1 h at 4'C. The beads were donsrem .igalngpa.wy........... washed three times with IP buffer bFfore being heated with sample buffer at 95'C for 5 min and analyzed by SDS-PAGE and Western blotting.
collaborative regulation of the distinct cellular behaviors of For Racl activity assay, the cells from t 0-d culture in 3D BM were lysed in GST-Fish buffer (10% glycerol, 50 iiM Tris, 1)11 7.4, 100 mM NaCl 1%.
tumor tissues (Fig. 7) . Significantly, our results also reveal NP-40, 2 mM MgCI:,, 10 jig/ml leupeptin, 10 ptg/ml pepstatin, 10 iLg/ml that increased cell proliferation (in the absence of a polarityaprotinin, 10 Rig/mI E 64, and 1 mM Pefabloc) and centrifuged at 106,0(0 g disrupting signal) is not sufficient to result in loss of tissue at 4°C. Equal amounts of protein supernatants were incubated with recombinant GST-PAK-CD fusion protein (containing the Rac and Cdc42 binding organization (Fig. 4 E) , a finding that may explain why Akt region from human PAKI1; Sander et al., 1998) , bound to glutathione-couoverexpression by itself is not sufficient to increase tumor inpled Sepharose beads (Amersham Biosciences) at 4'C for 30 min. The cidence as well.
beads were washed with an excess of lysis buffer, eluted in sample buffer,
In conclusion, we have used the 3D IrBM assay to deterand then analyzed by SDS-PAGE and Western blotting using antibody against Racl. mine the role of P13K signaling in the tumorigenic pheFor PiP3 immunofluorescence, the isolated colonies were fixed with notype, signaling reorganization, and tissue polarity of 3.7% formaldehyde, washed with CSK buffer (10 mM Hepes, 138 rnM
